What does PHARMACIE LECOMPT do?

PHARMACIE LECOMPT is a logistics company in Quaregnon. Private Limited, started on 30 June 2006, 1 establishment.

What is the address of PHARMACIE LECOMPT?

The registered office of PHARMACIE LECOMPT is located at Rue de Monsville 149, 7390 Quaregnon.

Is PHARMACIE LECOMPT still active?

Yes. According to the CBE (30 October 2026) PHARMACIE LECOMPT is active, legal situation “Normale toestand”, started on 30 June 2006.

Is PHARMACIE LECOMPT registered on Peppol?

Yes, PHARMACIE LECOMPT is registered on the Peppol network with ID 0208:0882201934.

What is the enterprise number of PHARMACIE LECOMPT?

The enterprise number of PHARMACIE LECOMPT is BE0882201934.

When was PHARMACIE LECOMPT founded?

PHARMACIE LECOMPT was founded on 30 June 2006.

Who are the directors of PHARMACIE LECOMPT?

According to the 2025 annual accounts, the directors of PHARMACIE LECOMPT are: LES PHARMACIES BENIT-DEHAUT-RION.

Is PHARMACIE LECOMPT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 June 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE LECOMPT make in 2025?

PHARMACIE LECOMPT posted a profit after taxes of € 11,871 in financial year 2025.

What is the revenue of PHARMACIE LECOMPT?

As a small company, PHARMACIE LECOMPT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 132,330.

PHARMACIE LECOMPT (Private Limited) - Quaregnon

Dossier PHARMACIE LECOMPT, printed on 30 October 2026 from databakkes.be/en/0882201934/pharmacie-lecompt. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 58 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE LECOMPT from Quaregnon, company number BE0882201934, closed financial year 2025 with a result of € 11,871 after tax. For that financial year PHARMACIE LECOMPT recorded a gross margin of € 132,330 and equity of € 40,022. Compared with financial year 2024, the result moved from € 34,615 to € 11,871. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 21, 2026.

What it is worth Healthy

€ 40,022

▼ 25% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 11,871

▼ 66% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 131,770

▲ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 25,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 45,460

▼ 22% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,449

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 175,734

▼ 17% vs 2024

€ 37,650 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 95,339

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,817

▼ 15% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 149,540 Gross margin 2022: € 149,540 First fiscal year in the series	€ 159,628 Gross margin 2023: € 159,628 ▲ 7% vs 2022 (€ 149,540) Favourable step	€ 153,516 Gross margin 2024: € 153,516 ▼ 4% vs 2023 (€ 159,628) Unfavourable step	€ 132,330 Gross margin 2025: € 132,330 ▼ 14% vs 2024 (€ 153,516) Unfavourable step	▼ 14%
Profit after taxes	€ 67,159 Profit after taxes 2022: € 67,159 First fiscal year in the series	€ 40,532 Profit after taxes 2023: € 40,532 ▼ 40% vs 2022 (€ 67,159) Unfavourable step	€ 34,615 Profit after taxes 2024: € 34,615 ▼ 15% vs 2023 (€ 40,532) Unfavourable step	€ 11,871 Profit after taxes 2025: € 11,871 ▼ 66% vs 2024 (€ 34,615) Unfavourable step	▼ 66%
Equity	€ 132,619 Equity 2022: € 132,619 First fiscal year in the series	€ 53,151 Equity 2023: € 53,151 ▼ 60% vs 2022 (€ 132,619) Unfavourable step	€ 53,151 Equity 2024: € 53,151 Unchanged (€ 53,151) Unchanged	€ 40,022 Equity 2025: € 40,022 ▼ 25% vs 2024 (€ 53,151) Unfavourable step	▼ 25%
Total debts	€ 296,888 Total debts 2022: € 296,888 First fiscal year in the series	€ 537,642 Total debts 2023: € 537,642 ▲ 81% vs 2022 (€ 296,888) Unfavourable step	€ 652,353 Total debts 2024: € 652,353 ▲ 21% vs 2023 (€ 537,642) Unfavourable step	€ 661,157 Total debts 2025: € 661,157 ▲ 1% vs 2024 (€ 652,353) Unfavourable step	▲ 1%
Cash	€ 95,189 Cash 2022: € 95,189 First fiscal year in the series	€ 162,253 Cash 2023: € 162,253 ▲ 70% vs 2022 (€ 95,189) Favourable step	€ 90,980 Cash 2024: € 90,980 ▼ 44% vs 2023 (€ 162,253) Unfavourable step	€ 131,770 Cash 2025: € 131,770 ▲ 45% vs 2024 (€ 90,980) Favourable step	▲ 45%
Land & buildings	€ 32,990 Land & buildings 2022: € 32,990 First fiscal year in the series	€ 101,092 Land & buildings 2023: € 101,092 ▲ 206% vs 2022 (€ 32,990) Unchanged	€ 230,471 Land & buildings 2024: € 230,471 ▲ 128% vs 2023 (€ 101,092) Unchanged	€ 204,371 Land & buildings 2025: € 204,371 ▼ 11% vs 2024 (€ 230,471) Unchanged	▼ 11%
Retained profit	€ 126,419 Retained profit 2022: € 126,419 First fiscal year in the series	€ 46,951 Retained profit 2023: € 46,951 ▼ 63% vs 2022 (€ 126,419) Unfavourable step	€ 46,951 Retained profit 2024: € 46,951 Unchanged (€ 46,951) Unchanged	€ 33,822 Retained profit 2025: € 33,822 ▼ 28% vs 2024 (€ 46,951) Unfavourable step	▼ 28%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 120,000 Dividend 2023: € 120,000 ▲ 300% vs 2022 (€ 30,000) Unchanged	€ 34,615 Dividend 2024: € 34,615 ▼ 71% vs 2023 (€ 120,000) Unchanged	€ 25,000 Dividend 2025: € 25,000 ▼ 28% vs 2024 (€ 34,615) Unchanged	▼ 28%
Bank debt	€ 178,609 Bank debt 2022: € 178,609 First fiscal year in the series	€ 290,644 Bank debt 2023: € 290,644 ▲ 63% vs 2022 (€ 178,609) Unfavourable step	€ 212,543 Bank debt 2024: € 212,543 ▼ 27% vs 2023 (€ 290,644) Favourable step	€ 175,734 Bank debt 2025: € 175,734 ▼ 17% vs 2024 (€ 212,543) Favourable step	▼ 17%
Balance sheet total	€ 429,507 Balance sheet total 2022: € 429,507 First fiscal year in the series	€ 590,792 Balance sheet total 2023: € 590,792 ▲ 38% vs 2022 (€ 429,507) Unchanged	€ 705,504 Balance sheet total 2024: € 705,504 ▲ 19% vs 2023 (€ 590,792) Unchanged	€ 701,179 Balance sheet total 2025: € 701,179 ▼ 1% vs 2024 (€ 705,504) Unchanged	▼ 1%

Key figures of PHARMACIE LECOMPT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE LECOMPT?

What happened at PHARMACIE LECOMPT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 21, 2026 New annual accounts for financial year 2025: profit of € 11,871 (▼ 66% vs 2024). filed late Source: NBB ↗
Jul 1, 2006 New establishment in Quaregnon. KBO
Jun 30, 2006 Start of the company according to the CBE. KBO

In short

From € 67,159 profit in 2022 to € 11,871 profit in 2025.

Paid € 41,338 in corporate taxes since 2022.

Best year ever: 2022, with € 67,159 profit.

Paid out € 209,615 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

LES PHARMACIES BENIT-DEHAUT-RION 100%

The stake of LES PHARMACIES BENIT-DEHAUT-RION comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE LECOMPT

Behind PHARMACIE LECOMPT is LES PHARMACIES BENIT-DEHAUT-RION. The shares are held by LES PHARMACIES BENIT-DEHAUT-RION (100%).

Directors

According to the 2025 annual accounts

LES PHARMACIES BENIT-DEHAUT-RION

Director · represented by Jacques Dehaut

Also active at: PHARMACIE JOSPIN, PHARMACIES LIEGEOIS, PHARMACIE MARIAGE, PHARMACIE DEHAUT, ADRIAENS-LOUIS, PHARMACIE DES VIADUCS, PHARMACIE PATURIAUX, Pharmacie des Câbleries +3 more

Shareholders

LES PHARMACIES BENIT-DEHAUT-RION

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Monsville 149

7390 Quaregnon

2.228.679.423

Rue Alfred Defuisseaux 126

7390 Quaregnon

Active since 1 July 2006

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0882.201.934

VAT number

BE 0882.201.934

Registered office

Rue de Monsville 149, 7390 Quaregnon

Names & denominations

PHARMACIE LECOMPT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 June 2006

Peppol

Active · Active since 20 Nov 2020

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE LECOMPT

Warning lights

Financials

What happened to PHARMACIE LECOMPT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions